Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.
Bishop MR, Iversen PL, Bayever E, Sharp JG, Greiner TC, Copple BL, Ruddon R, Zon G, Spinolo J, Arneson M, Armitage JO, Kessinger A.
Bishop MR, et al. Among authors: zon g.
J Clin Oncol. 1996 Apr;14(4):1320-6. doi: 10.1200/JCO.1996.14.4.1320.
J Clin Oncol. 1996.
PMID: 8648390
Clinical Trial.